The clinical-genealogic and molecular-genetic characteristics of oculopharyngeal muscular dystrophy in the Republic of Sakha (Yakutia)

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 108, Issue 6, 2008, Pages 52-60

  Maksimova, N R ^a   Nikolaeva, I A ^a   Korotov, M N ^a   Ikeuchi, T ^a   Onodera, O ^a   Nishizawa, M ^a   Stepanova, S K ^a   Kurtanov, Kh A ^a   Sukhomyasova, A L ^a   Nogovitcina, A N ^a   Gurinova, E E ^a   Stepanov, V A ^a   Puzyrev, V P ^a  

^a NONE

Author keywords

GCG repeats; Oculopharyngeal muscular dystrophy; PABPN1; Yakuts

Indexed keywords

EID: 49949089480     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Russian source
10. Becher M. W., Morrison L., Davis L.E. et al. Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans. JAMA 2001; 286: 2437-2440.
11. Blumen S.C., Brais B., Korczyn A.D. et al. Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Ann Neurol 1999; 46: 115-118.
12. Blumen S.C., Korczyn A.D., Lavoie H. et al. Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene. Neurology 2000; 1268-1270.
13. Bouchard J.-P. Brais B., Brunet D. et al. Recent studies on oculopharyngeal muscular dystrophy in Quebec. Neuromusc Disord 1997; 7: Suppl 1: S22-29.
14. Braise B., Bouchard J.-P., Xie Ya-G. et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Gen 1998; 18: 164-167.
15. Codere F., Brais B., Rouleau G., Lafontaine E. Oculopharyngeal muscualr dystrophy: What's new? Orbit 2001; 20: 259-266.
16. Gambelli S., Malandrini A., Ginanneschi F. et al. Mitochondrial Abnormalities in Genetically Assessed Oculopharyngeal Muscular Dystrophy. Eur Neurol 2004; 1: 44-147.
17. Hill M.E., Creed G.A., McMullan T.F.W. et al. Oculopharyngeal muscular dystrophy. Phenotypic and genotypic studies in a UK population. Brain 2001; 124: 522-526.
18. Maksimova N., Hara K., Miyashita A. et al. Clinical, molecular and histopathological featurea of short stature syndrome with novel CUL7 Mutation in Yakuts: new population isolate in Asia. J Med Genet Published Online First: 3 August 2007; doi:10.1136/jmg.2007.051979.
19. Mirabella M., Silvester G., Rosa G. et al. GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology 2000; 608-614.
20. Muller T., Schoroder R., Ziert S. GCG repeats and phenotype in oculopharyngeal muscular dystrophy. Musce & Nerve 2001; 24: 120-122
21. Nakamoto M., Nakano S., Kawashima Sh. et al. Unequal crossing-over in unique PABP2 mutations in Japanese patients. Arch neurol 2002; 59: 474-477.
22. Robinson D.O., Wills A.J., Hammans S.R. et al. Oculopharyngeal muscular dystrophy: a point mutation with mimics the effect of the PABPN1 gene triplet repeat expansion.; Med Genet 2006; 43: 23-24.
23. 11 founder mutation in the PABPN1 gene of OPMD Uruguayan families. Neuromusc Disord 2005; 15: 185-190.
24. Ruegg S., Hagen M.L., Hobl U. et al. Oculopharyngeal muscular dystrophy - an under-diagnosed disorder? Swiss Med Wlly 2005; 135: 574-586.
25. Victor M., Hayes R., Adams R.D. Oculopharyngeal muscular dystrophy. A Familial Disease of Late Life characterized y Dysphagia and Progressive Ptosis of the Eyelids. The New Engl J of Med 1962; 267: 1267-1272.
26. Uyama E., Tsukahara T., Goto K.M. et al. Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy. Muscle & Nerve 2000; 23: 1549-1554.